Hospital
De Queen Medical Center INC
De Queen Medical Center INC was paid $181K by Medicaid between Jan 2018 and Feb 2019, across 68 billing codes. Its largest line is 97530, Therapeutic activities, direct patient contact, each 15 minutes — 21% of everything it billed.
33Billing provider infoDE QUEEN MEDICAL CENTER INC
DE QUEEN, AR 71832
DE QUEEN, AR 71832
33aNPI1184612194assigned 10/12/2005
33bProvider typeCritical Access Hospital
28Total paid$181K
24GClaims14,210
24DCodes billed68
24AFirst – last monthJan 2018 – Feb 2019
Compared with peers
Next to other Critical Access Hospital providers in Arkansas
Rank by total paid#26 of 34
Median peer was paid$773K
This provider vs. median0.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,597 | $171K | |
| 2019 | 613 | $9K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 21% | 1,260 | 188 | $37K |
| 80053 | Comprehensive metabolic panel | 15% | 1,568 | 1,146 | $27K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 14% | 977 | 163 | $26K |
| 70450 | Computed tomography, head or brain; without contrast material | 5.9% | 98 | 86 | $11K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.1% | 1,529 | 1,096 | $9K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2.5% | 531 | 458 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.2% | 546 | 361 | $4K |
| 71046 | Radiologic examination, chest; 2 views | 2.2% | 256 | 220 | $4K |
| 82550 | 2.0% | 339 | 215 | $4K | |
| 80061 | Lipid panel | 2.0% | 287 | 248 | $4K |
| 86710 | 1.9% | 376 | 204 | $3K | |
| 82553 | 1.9% | 325 | 210 | $3K |
56 more codes
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.7% | 34 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.6% | 342 | $3K |
| 36415 | Collection of venous blood by venipuncture | 1.6% | 737 | $3K |
| 83880 | 1.5% | 172 | $3K | |
| 84484 | 1.4% | 328 | $3K | |
| 83655 | 1.3% | 187 | $2K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.2% | 202 | $2K |
| 80306 | <1% | 95 | $2K | |
| 82728 | <1% | 100 | $2K | |
| 83735 | <1% | 316 | $2K | |
| 71045 | Radiologic examination, chest; single view | <1% | 284 | $1K |
| 81001 | <1% | 500 | $1K | |
| 80050 | General health panel | <1% | 30 | $1K |
| 87430 | <1% | 125 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 227 | $1K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 56 | $1K |
| 83550 | <1% | 107 | $1K | |
| 72100 | <1% | 16 | $996.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 54 | $935.73 |
| 83540 | <1% | 111 | $851.00 | |
| 99285 | Emergency room visit (most serious) | <1% | 207 | $810.44 |
| 81003 | <1% | 241 | $616.71 | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 86 | $516.03 |
| 85044 | <1% | 77 | $429.80 | |
| 80323 | <1% | 37 | $410.31 | |
| 80356 | <1% | 68 | $390.40 | |
| 71110 | <1% | 20 | $390.00 | |
| 87420 | <1% | 38 | $386.10 | |
| 80346 | <1% | 68 | $330.66 | |
| 80348 | <1% | 68 | $325.05 | |
| 81025 | <1% | 50 | $305.90 | |
| 80358 | <1% | 68 | $295.50 | |
| 80364 | <1% | 68 | $295.50 | |
| 80345 | <1% | 68 | $280.90 | |
| 99283 | Emergency room visit (moderate) | <1% | 19 | $250.46 |
| 80324 | <1% | 68 | $250.19 | |
| 80337 | <1% | 67 | $244.62 | |
| 80370 | <1% | 37 | $240.84 | |
| 80353 | <1% | 68 | $230.10 | |
| 80349 | <1% | 68 | $213.50 | |
| 80368 | <1% | 68 | $213.50 | |
| 80355 | <1% | 68 | $201.90 | |
| 80366 | <1% | 66 | $192.61 | |
| 80359 | <1% | 68 | $192.15 | |
| 80351 | <1% | 37 | $192.15 | |
| 80371 | <1% | 36 | $128.10 | |
| 87186 | <1% | 36 | $120.85 | |
| 87088 | <1% | 12 | $98.97 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 35 | $62.76 |
| G0378 | Hospital observation service, per hour | 0% | 29 | $0.00 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 0% | 12 | $0.00 |
| A9270 | Non-covered item or service | 0% | 17 | $0.00 |
| 94664 | 0% | 21 | $0.00 | |
| 80369 | 0% | 18 | $0.00 | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 0% | 64 | $0.00 |
| 80372 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCAPSHEW, RYAN (CEO)
| Provider | Location | Paid |
|---|---|---|
| Cah Acquisition Company 4 INC | Drumright, OK | $160K |
| Cah Acquisition Company 4 INC | Drumright, OK | $118K |
| De Queen Medical Center INC | De Queen, AR | $30K |
| Cah Acquisition Company 4 INC | Drumright, OK | $5K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.